跳至主要内容
临床试验/IRCT2015083117719N2
IRCT2015083117719N2已完成3 期

PEG-Lactulose versus lactulose in the treatment of hepatic encephalopathy in cirrhotic patients in Shariati hospital.

Tehran University of Medical Sciences-Collaborative Office Between University,Industry and Society0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age 18 to 80 years old; Documented cirrhosis with any underlying etiology; Any grade of hepatic encephalopathy; Signed informed consent by patient or his/her LARs (if there is an imperfect level of consciousness)
  • Exclusion criteria: Acute liver failure that was defined as the onset of severe acute liver injury with encephalopathy and international normalized ratio (INR) of =1.5 in a patient without cirrhosis or preexisting liver disease; Altered mental status due to a diagnosis other than hepatic encephalopathy; Patient's or his/her LAR unwillingness to this trial; Hemodynamic instability which needs vasopressors for resuscitation; Pregnancy.

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Sciences-Collaborative Office Between University,Industry and Society

相似试验